T1	Participants 352 375	Twenty healthy subjects
T2	Participants 646 721	were measured at 10 min. intervals for 1 hour prior to drug administration,
T3	Participants 761 832	Misoprostol (400 mcg) or its matching placebo were administered orally,
T4	Participants 1054 1135	statistically significant decrease in heart rate between the two treatment groups
